Trust Company’s Amicus Therapeutics FOLD Stock Holding History

Trust Company’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-61	Closed	-$882	–	927
2026 Q1	$882	Hold	61	–	–	﹤0.01%	596
2025 Q4	$869	Buy	+61	New	+$599	﹤0.01%	580

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Trust Company's FOLD Position: Q2 2026 in Review

Trust Company sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 61 shares — an estimated $882 sold.

Trust Company first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $882 in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

Trust Company reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Trust Company sold 61 Amicus Therapeutics shares in Q2 2026, an estimated $882.
Trust Company first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Trust Company's Amicus Therapeutics position peaked at $882 in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.